Aaron M. LeBeau

968 total citations
28 papers, 686 citations indexed

About

Aaron M. LeBeau is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Aaron M. LeBeau has authored 28 papers receiving a total of 686 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 14 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Aaron M. LeBeau's work include Peptidase Inhibition and Analysis (13 papers), Protease and Inhibitor Mechanisms (8 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Aaron M. LeBeau is often cited by papers focused on Peptidase Inhibition and Analysis (13 papers), Protease and Inhibitor Mechanisms (8 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Aaron M. LeBeau collaborates with scholars based in United States, Denmark and Brazil. Aaron M. LeBeau's co-authors include Samuel R. Denmeade, Saurabh Aggarwal, W. Nathaniel Brennen, Charles S. Craik, John T. Isaacs, Pratap Singh, Sai Duriseti, Henry F. VanBrocklin, Stephanie T. Murphy and Daniel R. Hostetter and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Biochemistry.

In The Last Decade

Aaron M. LeBeau

26 papers receiving 676 citations

Peers

Aaron M. LeBeau
Liliana Guzman‐Rojas United States
С. В. Вторушин Russia
Tatsuya Inui Japan
Jay S. Lillquist United States
Majid Lotfinia Iran
Marta H. Kubala Australia
Christian Schmees Germany
Linda Schultz United States
Christopher Jedeszko United States
Sihe Zhang China
Liliana Guzman‐Rojas United States
Aaron M. LeBeau
Citations per year, relative to Aaron M. LeBeau Aaron M. LeBeau (= 1×) peers Liliana Guzman‐Rojas

Countries citing papers authored by Aaron M. LeBeau

Since Specialization
Citations

This map shows the geographic impact of Aaron M. LeBeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron M. LeBeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron M. LeBeau more than expected).

Fields of papers citing papers by Aaron M. LeBeau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron M. LeBeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron M. LeBeau. The network helps show where Aaron M. LeBeau may publish in the future.

Co-authorship network of co-authors of Aaron M. LeBeau

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron M. LeBeau. A scholar is included among the top collaborators of Aaron M. LeBeau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron M. LeBeau. Aaron M. LeBeau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gunaratne, Gihan S., Jason C. Mixdorf, Eduardo Aluicio‐Sarduy, et al.. (2025). The characterization of variable new antigen receptors targeting FAP isolated from a novel immunized library. Communications Biology. 8(1). 1210–1210.
2.
Gunaratne, Gihan S., Erika Héninger, Zachary T. Rosenkrans, et al.. (2024). Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein. Cancer Research Communications. 4(6). 1481–1494. 9 indexed citations
3.
Hoffmann, Mareike D., et al.. (2024). Unlocking precision gene therapy: harnessing AAV tropism with nanobody swapping at capsid hotspots. PubMed. 1(3). ugae008–ugae008. 6 indexed citations
4.
Emmerich, Philip B., et al.. (2024). Cancer-Associated Fibroblast Proteins as Potential Targets against Colorectal Cancers. Cancers. 16(18). 3158–3158. 10 indexed citations
5.
Lake, Eric W., et al.. (2024). Identification and biophysical characterization of a novel domain-swapped camelid antibody specific for fentanyl. Journal of Biological Chemistry. 300(8). 107502–107502. 1 indexed citations
6.
7.
Ye, Gang, Jian Zheng, Ke Shi, et al.. (2021). The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates. eLife. 10. 40 indexed citations
8.
Demir, Özlem, Fredy Kurniawan, William L. Brown, et al.. (2021). Structural Characterization of a Minimal Antibody against Human APOBEC3B. Viruses. 13(4). 663–663. 2 indexed citations
9.
Snyder, Kristin M., et al.. (2021). Simultaneous Engagement of Tumor and Stroma Targeting Antibodies by Engineered NK-92 Cells Expressing CD64 Controls Prostate Cancer Growth. Cancer Immunology Research. 9(11). 1270–1282. 13 indexed citations
10.
Chen, Lang, Michael B. Winter, Yang Yang, et al.. (2017). The Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach. Scientific Reports. 7(1). 1424–1424. 39 indexed citations
11.
LeBeau, Aaron M., Natalia Sevillano, Kate Markham, et al.. (2015). Imaging Active Urokinase Plasminogen Activator in Prostate Cancer. Cancer Research. 75(7). 1225–1235. 25 indexed citations
12.
Page, Michael J., André Luiz Lourenço, Tovo David, et al.. (2015). Non-invasive imaging and cellular tracking of pulmonary emboli by near-infrared fluorescence and positron-emission tomography. Nature Communications. 6(1). 8448–8448. 38 indexed citations
13.
LeBeau, Aaron M., Natalia Sevillano, Mandy L. King, et al.. (2014). Imaging the Urokinase Plasminongen Activator Receptor in Preclinical Breast Cancer Models of Acquired Drug Resistance. Theranostics. 4(3). 267–279. 28 indexed citations
14.
LeBeau, Aaron M. & Samuel R. Denmeade. (2014). Protease-Activated Pore-Forming Peptides for the Treatment and Imaging of Prostate Cancer. Molecular Cancer Therapeutics. 14(3). 659–668. 7 indexed citations
15.
LeBeau, Aaron M., Sai Duriseti, Stephanie T. Murphy, et al.. (2013). Targeting uPAR with Antagonistic Recombinant Human Antibodies in Aggressive Breast Cancer. Cancer Research. 73(7). 2070–2081. 68 indexed citations
16.
Duriseti, Sai, David H. Goetz, Daniel R. Hostetter, et al.. (2010). Antagonistic Anti-urokinase Plasminogen Activator Receptor (uPAR) Antibodies Significantly Inhibit uPAR-mediated Cellular Signaling and Migration. Journal of Biological Chemistry. 285(35). 26878–26888. 52 indexed citations
17.
LeBeau, Aaron M., Pratap Singh, John T. Isaacs, & Samuel R. Denmeade. (2009). Prostate-Specific Antigen Is a “Chymotrypsin-like” Serine Protease with Unique P1 Substrate Specificity. Biochemistry. 48(15). 3490–3496. 38 indexed citations
18.
Singh, Pratap, Aaron M. LeBeau, Hans Lilja, Samuel R. Denmeade, & John T. Isaacs. (2009). Molecular insights into substrate specificity of prostate specific antigen through structural modeling. Proteins Structure Function and Bioinformatics. 77(4). 984–993. 13 indexed citations
19.
LeBeau, Aaron M., Pratap Singh, John T. Isaacs, & Samuel R. Denmeade. (2008). Potent and Selective Peptidyl Boronic Acid Inhibitors of the Serine Protease Prostate-Specific Antigen. Chemistry & Biology. 15(7). 665–674. 55 indexed citations
20.
Zheng, Weiping, Dirk Schwarzer, Aaron M. LeBeau, et al.. (2005). Cellular Stability of Serotonin N-Acetyltransferase Conferred by Phosphonodifluoromethylene Alanine (Pfa) Substitution for Ser-205. Journal of Biological Chemistry. 280(11). 10462–10467. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liliana Guzman‐Rojas Breakdown of academic impact, for papers by С. В. Вторушин Breakdown of academic impact, for papers by Tatsuya Inui Breakdown of academic impact, for papers by Jay S. Lillquist Breakdown of academic impact, for papers by Majid Lotfinia Breakdown of academic impact, for papers by Marta H. Kubala Breakdown of academic impact, for papers by Christian Schmees Breakdown of academic impact, for papers by Linda Schultz Breakdown of academic impact, for papers by Christopher Jedeszko Breakdown of academic impact, for papers by Sihe Zhang
Rankless by CCL
2026